focus -WSS

focus

author：explore 2025-10-01 15:31:37 - browse：253

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Ukrainian soldiers say they owe lives to US

focus

WSS

To avoid data mishandling cases, universities eye AI and other tools

GOP inquiry over gain

Medical experts exlpore how to eliminate bias in clinical algorithms

Medicare threatens to cut off funding for HCA's Mission hospital

Ukrainian soldiers say they owe lives to US

Brazil's Jair Bolsonaro is barred from running for office until 2030

hotspot

focus

explore

Trump demands the U.S. pay no more for drugs than other countries … again

The strange history of BMI, the body mass index

Medicare details structure of new drug price negotiation program

Industry veterans launch new biotech VC with $310M

Drug repurposing or repositioning? The language matters

KalVista pill reduced swelling 'attacks' caused by genetic disease

Malaria cases in Florida and Texas: Here’s what you need to know

The strange history of BMI, the body mass index

Wildfire smoke exposes gaps in outdoor worker protections

For Medicare Advantage, Democrats want stronger protections around AI

focus

For Medicare Advantage, Democrats want stronger protections around AI

ADA: All diabetes patients should be screened for liver condition

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

PhRMA lawsuit over Medicare drug price negotiation tossed

Medicare threatens to cut off funding for HCA's Mission hospital

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Wikipedia

focus

focus

leisure time